FLT-PET analysis of early response to everolimus in newly diagnosed glioblastoma patients enrolled on NCCTG N057K.
J. N. Sarkaria
Research Funding - Merck; Novartis
P. J. Peller
No relevant relationships to disclose
E. Galanis
No relevant relationships to disclose
M. S. Jacobson
No relevant relationships to disclose
W. Wu
No relevant relationships to disclose
K. A. Jaeckle
No relevant relationships to disclose
J. C. Buckner
No relevant relationships to disclose